Cargando…

Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)

For glioblastoma, the treatment with standard of care therapy comprising resection, radiation, and temozolomide results in overall survival of approximately 14-18 months after initial diagnosis. Even though several new therapy approaches are under investigation, it is difficult to achieve life prolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Renner, Olga, Burkard, Markus, Michels, Holger, Vollbracht, Claudia, Sinnberg, Tobias, Venturelli, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104923/
https://www.ncbi.nlm.nih.gov/pubmed/33955499
http://dx.doi.org/10.3892/ijo.2021.5215